These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1380 related articles for article (PubMed ID: 26328268)

  • 1. Erratum: Achilles' heel of triple negative cancer.
    Ocaña A; Montero JC; Pandiella A
    Oncoscience; 2015; 2(7):659. PubMed ID: 26328268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERRATUM.
    Int J Bioprint; 2020; 6(4):309. PubMed ID: 33102924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum.
    Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum.
    J Indian Soc Periodontol; 2021; 25(3):270. PubMed ID: 34158698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.
    Chou CW; Yang RY; Chan LC; Li CF; Sun L; Lee HH; Lee PC; Sher YP; Ying H; Hung MC
    Am J Cancer Res; 2020; 10(10):3507. PubMed ID: 33163286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: An Erratum to Correct Typographical Errors.
    Ann Rehabil Med; 2016 Dec; 40(6):1151. PubMed ID: 28119849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: An Erratum to Correct Typographical Errors.
    Ann Rehabil Med; 2016 Oct; 40(5):959. PubMed ID: 27847729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.
    Xu C; Yu J; Wu F; Li X; Hu D; Chen G; Wu G
    Am J Transl Res; 2023; 15(7):4970. PubMed ID: 37560220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: ERRATUM.
    Indian J Anaesth; 2011 Mar; 55(2):121. PubMed ID: 21712866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: ERRATUM.
    Urol Ann; 2011 May; 3(2):61. PubMed ID: 21747592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum to: Conference materials. 15
    Cent Eur J Immunol; 2016; 41(4):442. PubMed ID: 28559744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achilles' heel of triple negative cancer.
    Ocaña A; Montero JC; Pandiella A
    Oncoscience; 2014; 1(2):115-6. PubMed ID: 25594005
    [No Abstract]   [Full Text] [Related]  

  • 13. Achilles' heel of triple negative cancer.
    Ocaña A; Montero JC; Pandiella A
    Oncoscience; 2014; 1(12):763-4. PubMed ID: 25621292
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum: Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD.
    Tuberc Respir Dis (Seoul); 2016 Jul; 79(3):193. PubMed ID: 27433181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers.
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):76-80. PubMed ID: 31265522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Author Corrections.
    Obstet Gynecol Sci; 2018 Sep; 61(5):645. PubMed ID: 30255004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum.
    Chin J Cancer Res; 2015 Apr; 27(2):E1. PubMed ID: 25937785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum.
    Can J Respir Ther; 2015; 51(3):72. PubMed ID: 26283873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum.
    Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
    Clin Mol Hepatol; 2015 Mar; 21(1):104. PubMed ID: 25834809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Addendum of Informed Consent Statements.
    Endocrinology and Metabolism Editorial Office
    Endocrinol Metab (Seoul); 2018 Mar; 33(1):137. PubMed ID: 29589396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.